APA (7th ed.) Citation

Jun-Ke Long, Wen Dai, Ya-Wen Zheng, & Shui-Ping Zhao. (2019). miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. BMC.

Chicago Style (17th ed.) Citation

Jun-Ke Long, Wen Dai, Ya-Wen Zheng, and Shui-Ping Zhao. MiR-122 Promotes Hepatic Lipogenesis via Inhibiting the LKB1/AMPK Pathway by Targeting Sirt1 in Non-alcoholic Fatty Liver Disease. BMC, 2019.

MLA (9th ed.) Citation

Jun-Ke Long, et al. MiR-122 Promotes Hepatic Lipogenesis via Inhibiting the LKB1/AMPK Pathway by Targeting Sirt1 in Non-alcoholic Fatty Liver Disease. BMC, 2019.